1-Minute Consult
How should we advise patients about the contraceptive patch, given the FDA warning?
Holly L. Thacker, MD, Tommaso Falcone, MD, Ashish Atreja, MD, MPH, Anil Jain, MD and C. Martin Harris, MD, MBA
Cleveland Clinic Journal of Medicine January 2006, 73 (1) 45-47;
Holly L. Thacker
Women’s Health Center at The Gault Women’s Health and Breast Pavilion, Department of General Internal Medicine, Department of Obstetrics and Gynecology, The Cleveland Clinic Foundation; Associate Professor of Medicine, Cleveland Clinic Lerner College of Medicine of Case-Western Reserve University
Roles: Director
Tommaso Falcone
Department of Obstetrics and Gynecology, The Cleveland Clinic Foundation; Professor of Medicine, Cleveland Clinic Lerner College of Medicine of Case-Western Reserve University
Roles: Chairman
Ashish Atreja
Medical Informatics Fellowship, Department of General Internal Medicine, The Cleveland Clinic Foundation
Roles: Associate Program Director
Anil Jain
Department of General Internal Medicine, The Cleveland Clinic Foundation
C. Martin Harris
Information Technology Division, Department of Internal Medicine, The Cleveland Clinic Foundation
Roles: Chief Information Officer, Chairman


This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Cleveland Clinic Journal of Medicine
Vol. 73, Issue 1
1 Jan 2006
How should we advise patients about the contraceptive patch, given the FDA warning?
Holly L. Thacker, Tommaso Falcone, Ashish Atreja, Anil Jain, C. Martin Harris
Cleveland Clinic Journal of Medicine Jan 2006, 73 (1) 45-47;
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.